Which statement about lab monitoring frequency is correct for home PN?

Prepare for the ASPEN Certified Nutrition Support Clinician (CNSC) Exam. Study with structured quizzes and detailed insights to enhance your knowledge and readiness. Get set for success!

Multiple Choice

Which statement about lab monitoring frequency is correct for home PN?

Explanation:
Monitoring lab tests in home parenteral nutrition is guided by how stable the patient’s course is and how likely complications are to develop. Right after starting PN or making changes, labs are checked frequently to catch metabolic shifts early and to adjust the prescription as needed. Once the patient has been clinically stable and the PN formula hasn’t required changes for a period, many programs systematically space labs out to reduce burden while still maintaining safety. In such stable patients, a common interval is every few weeks to monitor electrolytes, liver enzymes, triglycerides, glucose, and renal function, with some programs extending to about every two months if the patient remains stable and there are no concerning trends. This approach balances the need to detect problems promptly with practical considerations of frequent blood draws at home. If any abnormalities arise, or if there are changes in medications, comorbidities, or the PN formulation, the follow-up interval is shortened again.

Monitoring lab tests in home parenteral nutrition is guided by how stable the patient’s course is and how likely complications are to develop. Right after starting PN or making changes, labs are checked frequently to catch metabolic shifts early and to adjust the prescription as needed. Once the patient has been clinically stable and the PN formula hasn’t required changes for a period, many programs systematically space labs out to reduce burden while still maintaining safety. In such stable patients, a common interval is every few weeks to monitor electrolytes, liver enzymes, triglycerides, glucose, and renal function, with some programs extending to about every two months if the patient remains stable and there are no concerning trends. This approach balances the need to detect problems promptly with practical considerations of frequent blood draws at home. If any abnormalities arise, or if there are changes in medications, comorbidities, or the PN formulation, the follow-up interval is shortened again.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy